What are the properties of Green Chireta in supplements?

Green Chireta - References & External links

Green Chireta (Andrographis Paniculata)

The references to scientific articles about Green Chireta are not meant to imply that any products treat, cure, or diagnose any disease or human condition. We encourage our audience to do their own research beyond the resources we have provided so your decision is as educated as possible.

• Influence of Green Chireta on the Immune Response:
  It was demonstrate that andrographolide, an active component of Andrographis paniculata, exerts substantial antiviral activity against EV-D68 infection.
  • WANG, Dongyin; et al. Andrographolide Prevents EV-D68 Replication by Inhibiting the Acidification of Virus-Containing Endocytic Vesicles. Frontiers in microbiology, 2018, 9: 2407. PMID:30349523
  • JIANG, Yunhe; et al. Methyl-β-cyclodextrin Inhibits EV-D68 Virus Entry by Perturbing the Accumulation of Virus Particles and ICAM-5 in Lipid Rafts. Antiviral Research, 2020, 4.176: 104752. PMID:32101770
  • MULUYE, Rekik A.; BIAN, Yuhong; ALEMU, Paulos N. Anti-inflammatory and Antimicrobial Effects of Heat-Clearing Chinese Herbs: A Current Review. Journal of traditional and complementary medicine, 2014, 4.2: 93-98. PMID:24860732
  • PURI, Anju; et al. Immunostimulant Agents From Andrographis Paniculata. Journal of Natural Products, 1993, 56.7: 995-999. PMID:8377022
  • KO, Han-Chieh; WEI, Bai-Luh; CHIOU, Wen-Fei. The Effect of Medicinal Plants Used in Chinese Folk Medicine on RANTES Secretion by Virus-Infected Human Epithelial Cells. Journal of ethnopharmacology, 2006, 107.2: 205-210. PMID:16621378
  • RAMALINGAM, Senthilraja; et al. Anti-dengue Activity of Andrographis paniculata Extracts and Quantification of Dengue Viral Inhibition by SYBR Green Reverse Transcription Polymerase Chain Reaction. Ayu, 2018, 39.2: 87. PMID:30783363
    Conclusion: Ethanolic extracts treated with dengue VLs also showed a significant changes which were reflected in RT PCR assay.
• The properties of Green Chireta preventing Cold / Flu:
  • ROXAS, Mario; JURENKA, Julie. Colds and Influenza: A Review of Diagnosis and Conventional, Botanical, and Nutritional Considerations. Alternative Medicine Review, 2007, 12.1: . PMID:17397266
  • MELCHIOR, J.; PALM, S.; WIKMAN, G. Controlled Clinical Study of Standardized Andrographis Paniculata Extract in Common Cold - A Pilot Trial. Phytomedicine, 1997, 3.4: 315-318. PMID:23195187
  • WANG, Qiuhong; et al. Naturally Derived Anti-Inflammatory Compounds From Chinese Medicinal Plants. Journal of ethnopharmacology, 2013, 146.1: 9-39. PMID:23274744
    Conclusion: CMM is used clinically to treat inflammation symptoms in TCM, and its effect is mediated by multiple targets through multiple active ingredients. Although scholars around the world have made studies on the anti-inflammatory studies of CMM from different pathways and aspects and have made substantial progress, further studies are warranted to delineate the inflammation actions in more cogency models, establish the toxicological profiles and quality standards, assess the potentials of CMM in clinical applications, and make more convenient preparations easy to administrate for patients. Development of the clinically anti-inflammatory drugs are also warranted.
  • LIU, Jun; WANG, Zheng-Tao; GE, Bao-Xue. Andrograpanin, Isolated From Andrographis Paniculata, Exhibits Anti-Inflammatory Property in Lipopolysaccharide-Induced Macrophage Cells Through Down-Regulating the p38 MAPKs Signaling Pathways. International immunopharmacology, 2008, 8.7: 951-958. PMID:18486905
• The properties of Green Chireta boosting Digestive Health:
  • NG, S. C.; et al. Systematic Review: The Efficacy of Herbal Therapy in Inflammatory Bowel Disease. Alimentary pharmacology & therapeutics, 2013, 38.8: 854-863. PMID:23981095
    Conclusions: Randomised controlled trials of herbal therapy for the treatment of IBD show encouraging results but studies remain limited and heterogenous. Larger controlled studies with stricter endpoints and better-defined patient groups are required to obtain more conclusive results on the use of CAM therapies in IBD.